Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation.

about

Mexiletine rescues a mixed biophysical phenotype of the cardiac sodium channel arising from the SCN5A mutation, N406K, found in LQT3 patients

P2860

Q58805534-206D6876-65E6-47CD-9726-A9AF1D342640

P2860

Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation.

Item

http://www.wikidata.org/entity/Q41104424

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation.

@en

type

Item

label

Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation.

@en

prefLabel

Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation.

@en

P1476

Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation.

@en

P2093

Chang-Sheng Ma

http://www.w3.org/2001/XMLSchema#string

Chuanyu Gao

http://www.w3.org/2001/XMLSchema#string

Datun Qi

http://www.w3.org/2001/XMLSchema#string

Gan-Xin Yan

http://www.w3.org/2001/XMLSchema#string

Guizhi Liu

http://www.w3.org/2001/XMLSchema#string

Jian-Zeng Dong

http://www.w3.org/2001/XMLSchema#string

Jiaqi Huang

http://www.w3.org/2001/XMLSchema#string

Xiaolin Xue

http://www.w3.org/2001/XMLSchema#string

Yanzhou Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Antiarrhythmic drug therapy for atrial fibrillation

Late Sodium Current in Human Atrial Cardiomyocytes from Patients in Sinus Rhythm and Atrial Fibrillation

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

Cardiovascular drugs. Dofetilide.

Late sodium current block for drug-induced long QT syndrome: Results from a prospective clinical trial

Predicting drug-induced slowing of conduction and pro-arrhythmia: identifying the 'bad' sodium current blockers.

Atrial fibrillation in congestive heart failure.

Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography

Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.

P31

scholarly article

P356

10.1161/JAHA.117.005482

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28522677

http://www.w3.org/2001/XMLSchema#string

P932

5524094

http://www.w3.org/2001/XMLSchema#string

Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation.

about

P2860

P2860

Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P577

P698

P932